BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

869 related articles for article (PubMed ID: 28437162)

  • 21. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
    Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ;
    J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
    Quon H; Vapiwala N; Forastiere A; Kennedy EB; Adelstein DJ; Boykin H; Califano JA; Holsinger FC; Nussenbaum B; Rosenthal DI; Siu LL; Waldron JN
    J Clin Oncol; 2017 Dec; 35(36):4078-4090. PubMed ID: 29064744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant cisplatin-based chemotherapy for resected NSCLC: one size fits all?
    Geiger S; Schlemmer M; Heinemann V; Stemmler HJ
    Anticancer Drugs; 2010 Oct; 21(9):799-804. PubMed ID: 20679887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline.
    Okawara G; Ung YC; Markman BR; Mackay JA; Evans WK;
    Lung Cancer; 2004 Apr; 44(1):1-11. PubMed ID: 15013578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.
    Choi NC; Carey RW; Daly W; Mathisen D; Wain J; Wright C; Lynch T; Grossbard M; Grillo H
    J Clin Oncol; 1997 Feb; 15(2):712-22. PubMed ID: 9053497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
    Hanna NH; Robinson AG; Temin S; Baker S; Brahmer JR; Ellis PM; Gaspar LE; Haddad RY; Hesketh PJ; Jain D; Jaiyesimi I; Johnson DH; Leighl NB; Moffitt PR; Phillips T; Riely GJ; Rosell R; Schiller JH; Schneider BJ; Singh N; Spigel DR; Tashbar J; Masters G
    J Clin Oncol; 2021 Mar; 39(9):1040-1091. PubMed ID: 33591844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer: Cancer and Leukemia Group B 9734.
    Perry MC; Kohman LJ; Bonner JA; Gu L; Wang X; Vokes EE; Green MR
    Clin Lung Cancer; 2007 Jan; 8(4):268-72. PubMed ID: 17311692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Singapore Cancer Network (SCAN) Guidelines for Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer.
    Singapore Cancer Network (SCAN) Lung Cancer Workgroup
    Ann Acad Med Singap; 2015 Oct; 44(10):440-8. PubMed ID: 26763062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
    J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.
    Douillard JY; Rosell R; De Lena M; Riggi M; Hurteloup P; Mahe MA;
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):695-701. PubMed ID: 18439766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer.
    Kassam F; Shepherd FA; Johnston M; Visbal A; Feld R; Darling G; Keshavjee S; Pierre A; Waddell T; Leighl NB
    J Thorac Oncol; 2007 Jan; 2(1):39-43. PubMed ID: 17410008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease.
    Wakelee H; Dubey S; Gandara D
    Oncologist; 2007 Mar; 12(3):331-7. PubMed ID: 17405898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Management of resectable non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party].
    Sculier JP;
    Rev Med Brux; 2014; 35(3):134-9. PubMed ID: 25102579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline.
    Rudin CM; Ismaila N; Hann CL; Malhotra N; Movsas B; Norris K; Pietanza MC; Ramalingam SS; Turrisi AT; Giaccone G
    J Clin Oncol; 2015 Dec; 33(34):4106-11. PubMed ID: 26351333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Goss G; Paszat L; Newman TE; Evans WK; Browman G
    Cancer Prev Control; 1998 Feb; 2(1):32-9. PubMed ID: 9765764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
    Hanna NH; Schneider BJ; Temin S; Baker S; Brahmer J; Ellis PM; Gaspar LE; Haddad RY; Hesketh PJ; Jain D; Jaiyesimi I; Johnson DH; Leighl NB; Phillips T; Riely GJ; Robinson AG; Rosell R; Schiller JH; Singh N; Spigel DR; Stabler JO; Tashbar J; Masters G
    J Clin Oncol; 2020 May; 38(14):1608-1632. PubMed ID: 31990617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
    Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B
    J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition).
    Robinson LA; Ruckdeschel JC; Wagner H; Stevens CW;
    Chest; 2007 Sep; 132(3 Suppl):243S-265S. PubMed ID: 17873172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.
    Milowsky MI; Rumble RB; Booth CM; Gilligan T; Eapen LJ; Hauke RJ; Boumansour P; Lee CT
    J Clin Oncol; 2016 Jun; 34(16):1945-52. PubMed ID: 27001593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.